Ihuman Inc Stock Analysis

Ihuman Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ihuman Inc last dividend was issued on the 17th of April 2025. iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the Peoples Republic of China. The company was founded in 1996 and is based in Beijing, the Peoples Republic of China. Ihuman Inc operates under Education Training Services classification in the United States and is traded on New York Stock Exchange. It employs 1119 people. To learn more about Ihuman Inc call Peng Dai at 86 10 5780 6606 or check out https://www.ihuman.com.

Ihuman Inc Investment Alerts

Ihuman Largest EPS Surprises

View All Earnings Estimates

Ihuman Stock Institutional Investors

Note, although Ihuman's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ihuman Market Capitalization

The company currently falls under 'Small-Cap' category with a market capitalization of 102.69 M.

Ihuman Profitablity

The company has Net Profit Margin (PM) of 0.13 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.08 %, which signifies that for every $100 of sales, it has a net operating income of $0.08.

Management Efficiency

Ihuman Inc has Return on Asset (ROA) of 0.0326 % which means that for every $100 of assets, it generated a profit of $0.0326. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1115 %, which means that it produced $0.1115 on every 100 dollars invested by current stockholders. Ihuman's management efficiency ratios could be used to measure how well Ihuman manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Ihuman's Return On Tangible Assets are increasing as compared to previous years. The Ihuman's current Return On Assets is estimated to increase to 0.07, while Return On Capital Employed is projected to decrease to 0.08. As of now, Ihuman's Return On Tangible Assets are increasing as compared to previous years. The Ihuman's current Fixed Asset Turnover is estimated to increase to 85.86, while Total Assets are projected to decrease to under 1 B.

Technical Drivers

As of the 17th of February 2026, Ihuman retains the Risk Adjusted Performance of (0.12), standard deviation of 2.83, and Market Risk Adjusted Performance of 0.5813. Ihuman technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Ihuman Inc Price Movement Analysis

Ihuman Outstanding Bonds

Ihuman Predictive Daily Indicators

Ihuman Forecast Models

Ihuman's time-series forecasting models are one of many Ihuman's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ihuman's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Ihuman Bond Ratings

Ihuman Inc financial ratings play a critical role in determining how much Ihuman have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Ihuman's borrowing costs.

Ihuman Inc Debt to Cash Allocation

Ihuman Inc reports 14.91 M of total liabilities with total debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from financial leverage. Ihuman Inc has a current ratio of 2.22, indicating that it is in good position to pay out its debt commitments in time. Note however, debt could still be an excellent tool for Ihuman to invest in growth at high rates of return.

Ihuman Total Assets Over Time

Ihuman Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Ihuman uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Ihuman Debt Ratio

1.15

It feels like most of the Ihuman's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Ihuman's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Ihuman, which in turn will lower the firm's financial flexibility.

Ihuman Corporate Bonds Issued

Ihuman Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ihuman prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ihuman shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ihuman. By using and applying Ihuman Stock analysis, traders can create a robust methodology for identifying Ihuman entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ihuman analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ihuman analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ihuman Inc stock analysis indicators help investors evaluate how Ihuman stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ihuman shares will generate the highest return on investment. By understating and applying Ihuman stock analysis, traders can identify Ihuman position entry and exit signals to maximize returns.

When running Ihuman's price analysis, check to measure Ihuman's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ihuman is operating at the current time. Most of Ihuman's value examination focuses on studying past and present price action to predict the probability of Ihuman's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ihuman's price. Additionally, you may evaluate how the addition of Ihuman to your portfolios can decrease your overall portfolio volatility.